Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
Mais filtros

Bases de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Biochim Biophys Acta ; 1817(7): 1095-106, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22433608

RESUMO

The mitochondriotropic compound 7-O-(4-triphenylphosphoniumbutyl)quercetin iodide (Q-7BTPI) in the µM concentration range caused necrotic death of cultured cells by acting as a prooxidant, with generation of superoxide anion in the mitochondria. Externally added membrane-permeating superoxide dismutase or catalase largely prevented death. Rescue by permeant catalase indicates that the toxicant is H(2)O(2), or reactive species derived from it. Rescue by permeant dismutase suggests the possibility of a chain mechanism of H(2)O(2) production, in which dismutation of superoxide constitutes a termination step. Oxidative stress was due to the presence of free phenolic hydroxyls and to accumulation in mitochondria, since the analogous mitochondriotropic per-O-methylated compound -3,3',4',5-tetra-O-methyl,7-O-(4-triphenylphosphoniumbutyl) quercetin iodide (QTM-7BTPI)-or Quercetin itself induced no or little superoxide production and cell death. Q-7BTPI did not cause a significant perturbation of the mitochondrial transmembrane potential or of respiration in cells. On the other hand its presence led to inhibition of glutathione peroxidase, an effect expected to accentuate oxidative stress by interfering with the elimination of H(2)O(2). An exogenous permeable glutathione precursor determined a strong increase of cellular glutathione levels but did not rescue the cells. Death induction was selective for fast-growing C-26 tumoral cells and mouse embryonic fibroblasts (MEFs) while sparing slow-growing MEFs. This suggests a possible use of Q-7BTPI as a chemotherapeutic agent.


Assuntos
Mitocôndrias/metabolismo , Quercetina/análogos & derivados , Quercetina/toxicidade , Animais , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/farmacologia , Morte Celular/efeitos dos fármacos , Respiração Celular/efeitos dos fármacos , Glutationa/metabolismo , Humanos , Peróxido de Hidrogênio/metabolismo , Células Jurkat , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Camundongos , Microscopia de Fluorescência , Mitocôndrias/efeitos dos fármacos , Modelos Biológicos , Quercetina/química , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo
2.
Biochim Biophys Acta ; 1797(2): 189-96, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19835835

RESUMO

Mitochondria-targeted polyphenols are being developed with the intent to intervene on the levels of reactive oxygen species (ROS) in mitochondria. Polyphenols being more than just anti-oxidants, the interaction of these derivatives with the organelles needs to be characterised. We have studied the effects of two quercetin derivatives, 3-(4-O-triphenylphosphoniumbutyl)quercetin iodide (Q3BTPI) and its tetracetylated analogue (QTA3BTPI), on the inner membrane aspecific permeability, transmembrane voltage difference and respiration of isolated rat liver mitochondria. While the effects of low concentrations were too small to be reliably defined, when used in the 5-20 microM range these compounds acted as inducers of the mitochondrial permeability transition (MPT), an effect due to pro-oxidant activity. Furthermore, Q3BTPI behaved as an uncoupler of isolated mitochondria, causing depolarisation and stimulating oxygen consumption. When applied to tetramethylrhodamine methyl ester (TMRM)-loaded HepG2 or Jurkat cells uptake of the compounds was predictably associated with a loss of TMRM fluorescence, but there was no indication of MPT induction. A production of superoxide could be detected in some cells upon prolonged incubation of MitoSOX-loaded cells with QTA3BTPI. The overall effects of these model mitochondriotropic polyphenols may thus differ considerably depending on whether their hydroxyls are protected or not and on the experimental system. In vivo assays will be needed for a definitive assessment of their bioactivities.


Assuntos
Potencial da Membrana Mitocondrial/efeitos dos fármacos , Mitocôndrias Hepáticas/efeitos dos fármacos , Quercetina/farmacologia , Respiração/efeitos dos fármacos , Superóxidos/metabolismo , Animais , Eletrodos , Fluorescência , Células Hep G2 , Humanos , Mitocôndrias Hepáticas/metabolismo , Consumo de Oxigênio , Quercetina/análogos & derivados , Ratos
3.
Pharmacol Res ; 63(1): 37-43, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20883786

RESUMO

Vascular endothelial growth factor (VEGF) is a key player in neo-angiogenesis; it sustains the progression of solid neoplasias, brain tumours included. It has recently been demonstrated that the use of antidepressants correlates with increasing VEGF levels in the central nervous system (CNS). In order to elucidate whether the most used natural antidepressant [St. John's wort (SJW) extract] modulates VEGF expression, possible relationship between≤µM hyperforin (Hyp, the bioactive component in SJW) and VEGF in CNS tumours has been now examined in medulloblastoma and glioblastoma cells. Real-time PCR and ELISA revealed that under Hyp VEGF expression increased more than three fold in DAOY medulloblastoma cells; while, U87 glioblastoma cells - constitutively expressing high VEGF levels - showed no significant differences. Moreover, Hyp induced endothelial pro-angiogenic behaviour in a multi-parametric Matrigel colonisation assay, and down-modulation of pro-MMP-2 and pro-MMP-9 activities as measured by gelatin zymography. Should these results be confirmed in vivo for this and other types of CNS tumour, the antidepressant use of SJW extracts must be carefully re-considered, in particular for brain tumour patients.


Assuntos
Antidepressivos/farmacologia , Neoplasias Encefálicas/metabolismo , Neoplasias Cerebelares/metabolismo , Glioblastoma/metabolismo , Meduloblastoma/metabolismo , Floroglucinol/análogos & derivados , Terpenos/farmacologia , Fator A de Crescimento do Endotélio Vascular/metabolismo , Antidepressivos/efeitos adversos , Apoptose/efeitos dos fármacos , Neoplasias Encefálicas/irrigação sanguínea , Neoplasias Encefálicas/genética , Compostos Bicíclicos com Pontes/efeitos adversos , Compostos Bicíclicos com Pontes/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Neoplasias Cerebelares/irrigação sanguínea , Neoplasias Cerebelares/genética , Relação Dose-Resposta a Droga , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/metabolismo , Precursores Enzimáticos/metabolismo , Ensaio de Imunoadsorção Enzimática , Gelatinases/metabolismo , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Glioblastoma/irrigação sanguínea , Glioblastoma/genética , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/genética , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Meduloblastoma/irrigação sanguínea , Meduloblastoma/genética , Neovascularização Fisiológica/efeitos dos fármacos , Floroglucinol/efeitos adversos , Floroglucinol/farmacologia , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Terpenos/efeitos adversos , Transcrição Gênica/efeitos dos fármacos , Transfecção , Regulação para Cima , Fator A de Crescimento do Endotélio Vascular/genética
4.
Environ Health ; 10: 59, 2011 Jun 17.
Artigo em Inglês | MEDLINE | ID: mdl-21679472

RESUMO

BACKGROUND: Whether or not there is a relationship between use of mobile phones (analogue and digital cellulars, and cordless) and head tumour risk (brain tumours, acoustic neuromas, and salivary gland tumours) is still a matter of debate; progress requires a critical analysis of the methodological elements necessary for an impartial evaluation of contradictory studies. METHODS: A close examination of the protocols and results from all case-control and cohort studies, pooled- and meta-analyses on head tumour risk for mobile phone users was carried out, and for each study the elements necessary for evaluating its reliability were identified. In addition, new meta-analyses of the literature data were undertaken. These were limited to subjects with mobile phone latency time compatible with the progression of the examined tumours, and with analysis of the laterality of head tumour localisation corresponding to the habitual laterality of mobile phone use. RESULTS: Blind protocols, free from errors, bias, and financial conditioning factors, give positive results that reveal a cause-effect relationship between long-term mobile phone use or latency and statistically significant increase of ipsilateral head tumour risk, with biological plausibility. Non-blind protocols, which instead are affected by errors, bias, and financial conditioning factors, give negative results with systematic underestimate of such risk. However, also in these studies a statistically significant increase in risk of ipsilateral head tumours is quite common after more than 10 years of mobile phone use or latency. The meta-analyses, our included, examining only data on ipsilateral tumours in subjects using mobile phones since or for at least 10 years, show large and statistically significant increases in risk of ipsilateral brain gliomas and acoustic neuromas. CONCLUSIONS: Our analysis of the literature studies and of the results from meta-analyses of the significant data alone shows an almost doubling of the risk of head tumours induced by long-term mobile phone use or latency.


Assuntos
Neoplasias Encefálicas/etiologia , Telefone Celular , Neoplasias Induzidas por Radiação/etiologia , Neuroma Acústico/etiologia , Neoplasias das Glândulas Salivares/etiologia , Neoplasias Encefálicas/epidemiologia , Estudos Epidemiológicos , Humanos , Neoplasias Induzidas por Radiação/epidemiologia , Neuroma Acústico/epidemiologia , Razão de Chances , Reprodutibilidade dos Testes , Projetos de Pesquisa , Medição de Risco , Fatores de Risco , Neoplasias das Glândulas Salivares/epidemiologia
5.
BMC Vet Res ; 7: 33, 2011 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-21726449

RESUMO

BACKGROUND: Malignant canine mammary tumors represent 50% of all neoplasms in female dogs. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are thought to be involved in tumor progression, and they are also associated with the reactive stroma, which provides structural and vascular support for tumor growth. RESULTS: MMP-2, MMP-9 and MT1-MMP were expressed at both the mRNA and protein levels in tumor samples. MMP-2 and MMP-9 immunohistochemical reactions were evident both in the epithelial tumor cells and in the stromal compartment to varying degrees; in particular, the intensity of the MMP-2 staining was stronger in the stromal fibroblasts close to epithelial tumor cells in simple carcinomas than in adenomas. These data were supported by gelatin-zymography; bands for the active form of MMP-2 were found in 94% of carcinoma samples, compared with 17% of benign tumor samples. The gene expression and immunohistochemical results for MT1-MMP were comparable to those for MMP-2. The immunoreactivity for MMP-13 and TIMP-2 was lower in carcinomas than in adenomas, confirming the mRNA data for MMP-13 and the other MMP inhibitors that were evaluated. The active form of MMP-9, but not the active form of MMP-2, was identified in the plasma of all of the tested dogs. CONCLUSIONS: Our findings suggest that MMP-9, MMP-2 and MT1-MMP, which are synthesized by epithelial cancer cells and cancer-associated fibroblasts, play an important role in malignant canine mammary tumors. The reduction of MMP-13 and TIMP-2 could also be a significant step in malignant transformation. MMP-2 and MT1-MMP could be further evaluated as future biomarkers for predicting the progression and prognosis of canine mammary tumors.


Assuntos
Doenças do Cão/metabolismo , Neoplasias Mamárias Animais/metabolismo , Metaloproteinases da Matriz/metabolismo , Inibidores Teciduais de Metaloproteinases/metabolismo , Animais , DNA de Neoplasias/metabolismo , Cães , Feminino , Metaloproteinase 13 da Matriz/metabolismo , Metaloproteinase 14 da Matriz/metabolismo , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa/veterinária , Inibidor Tecidual de Metaloproteinase-1/metabolismo , Inibidor Tecidual de Metaloproteinase-3/metabolismo
6.
Epidemiol Prev ; 35(3-4): 188-99, 2011.
Artigo em Italiano | MEDLINE | ID: mdl-21914915

RESUMO

The uncertainty about the relationship between the use of mobile phones (MPs: analogue and digital cellulars, and cordless) and the increase of head tumour risk can be solved by a critical analysis of the methodological elements of both the positive and the negative studies. Results by Hardell indicate a cause/effect relationship: exposures for or latencies from ≥ 10 years to MPs increase by up to 100% the risk of tumour on the same side of the head preferred for phone use (ipsilateral tumours) - which is the only one significantly irradiated - with statistical significance for brain gliomas, meningiomas and acoustic neuromas. On the contrary, studies published under the Interphone project and others produced negative results and are characterised by the substantial underestimation of the risk of tumour. However, also in the Interphone studies a clear and statistically significant increase of ipsilateral head tumours (gliomas, neuromas and parotid gland tumours) is quite common in people having used MPs since or for ≥ 10 years. And also the metaanalyses by Hardell and other Authors, including only the literature data on ipsilateral tumours in people having used MPs since or for ≥ 10 years - and so also part of the Interphone data - still show statistically significant increases of head tumours.


Assuntos
Telefone Celular , Neoplasias de Cabeça e Pescoço/etiologia , Ondas de Rádio/efeitos adversos , Viés , Neoplasias Encefálicas/epidemiologia , Neoplasias Encefálicas/etiologia , Neoplasias Encefálicas/prevenção & controle , Estudos de Casos e Controles , Causalidade , Conflito de Interesses , Neoplasias de Cabeça e Pescoço/epidemiologia , Neoplasias de Cabeça e Pescoço/prevenção & controle , Humanos , Metanálise como Assunto , Estudos Multicêntricos como Assunto/estatística & dados numéricos , Risco , Fatores de Tempo
7.
Biochim Biophys Acta ; 1787(12): 1425-32, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19523917

RESUMO

The Ca(2+)- and oxidative stress-induced mitochondrial permeability transition (MPT) plays an important role in phenomena ranging from tissue damage upon infarction to muscle wasting in some forms of dystrophy. The process is due to the activation of a large pore in the inner mitochondrial membrane. Anti-oxidants are considered a preventive and remedial tool, and mitochondria-targeted redox-active compounds have been developed. Plant polyphenols are generally considered as anti-oxidants, and thus candidates to the role of mitochondria-protecting agents. In patch-clamp experiments, easily oxidizable polyphenols induced closure of the MPT channel. In swelling experiments with suspensions of mitochondria, high (20-50 microM) concentrations of quercetin, the most efficient inhibitor, promoted instead the onset of the MPT. Chelators of Fe(2+/3+) and Cu(+/2+) ions counteracted this effect. Fluorescent indicators of superoxide production confirmed that quercetin potentiates O(2)(*-) generation by isolated mitochondria and cultured cells. Since this was not affected by chelating Fe and Cu ions, the MPT-inducing effect can be ascribed to a "secondary", metal ion-catalyzed production of ROS. These results are a direct demonstration of the ambivalent redox character of polyphenols. Their mode of action in vivo cannot be taken for granted, but needs to be experimentally verified.


Assuntos
Flavonoides/farmacologia , Proteínas de Transporte da Membrana Mitocondrial/efeitos dos fármacos , Fenóis/farmacologia , Quercetina/farmacologia , Células HCT116 , Humanos , Poro de Transição de Permeabilidade Mitocondrial , Oxirredução , Polifenóis , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo
8.
J Pharmacol Exp Ther ; 332(3): 785-94, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19959748

RESUMO

Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory cytokines. Because bleomycin (BLM) causes lung injury, which is characterized by an inflammatory response followed by a fibrotic degeneration, we postulated that blocking GSK-3 activity with a specific inhibitor could affect the inflammatory and profibrotic cytokine network generated in the BLM-induced process of pulmonary inflammation and fibrosis. Thus, here we investigated the effects of the GSK-3 inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) on a BLM-induced lung fibrosis model in mice. SB216763 prevented lung inflammation and the subsequent fibrosis when coadministered with BLM. Bronchoalveolar lavage fluid analysis of mice treated with BLM plus SB216763 revealed a significant reduction in BLM-induced alveolitis. Furthermore, SB216763 treatment was associated with a significantly lower production of inflammatory cytokines by macrophages. BLM-treated mice that received SB216763 developed alveolar epithelial cell damage and pulmonary fibrosis to a significantly lower extent compared with BLM-treated controls. These findings suggest that GSK-3 inhibition has a protective effect on lung fibrosis induced by BLM and candidate GSK-3 as a potential therapeutic target for preventing pulmonary fibrosis.


Assuntos
Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Fibrose Pulmonar Idiopática/tratamento farmacológico , Indóis/uso terapêutico , Pulmão/efeitos dos fármacos , Maleimidas/uso terapêutico , Pneumonia/tratamento farmacológico , Mucosa Respiratória/efeitos dos fármacos , Animais , Bleomicina , Quimiocina CCL2/biossíntese , Fibrose Pulmonar Idiopática/induzido quimicamente , Fibrose Pulmonar Idiopática/imunologia , Fibrose Pulmonar Idiopática/patologia , Pulmão/imunologia , Pulmão/patologia , Macrófagos/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Pneumonia/induzido quimicamente , Pneumonia/imunologia , Pneumonia/patologia , Alvéolos Pulmonares/efeitos dos fármacos , Alvéolos Pulmonares/patologia , Mucosa Respiratória/patologia , Fator de Necrose Tumoral alfa/biossíntese
9.
Molecules ; 15(9): 6570-9, 2010 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-20877244

RESUMO

Resveratrol (trans-3,4',5-trihydroxystilbene) and quercetin (3,3',4',5,7-pentahydroxyflavone) are two naturally occurring polyphenols with the potential to exert beneficial health effects. Since their low bioavailability is a major obstacle to biomedical applications, efforts are being made to improve their absorption and slow down phase II metabolism. An accurate evaluation of the corresponding levels in the bloodstream is important to assess delivery strategies, as well as to verify claims of efficacy based on in vitro results. In the present work we have optimized a simple method ensuring complete stabilization and extraction of resveratrol and quercetin from whole blood. The suitability of different protocols was evaluated by measuring the recovery of polyphenol and internal standard from spiked blood samples via HPLC/UV analysis. The optimized procedure ensured a satisfactory recovery of both internal standards and compounds. Comparing plasma and whole blood, up to 76% of the analyte, being associated with the cellular fraction, was unaccounted for when examining only plasma. This indicates the importance of analysing whole blood rather than plasma to avoid underestimating polyphenol absorption in bioavailability studies.


Assuntos
Quercetina/sangue , Estilbenos/sangue , Disponibilidade Biológica , Cromatografia Líquida de Alta Pressão , Flavonoides/sangue , Flavonoides/normas , Humanos , Métodos , Fenóis/sangue , Fenóis/normas , Polifenóis , Quercetina/farmacocinética , Padrões de Referência , Resveratrol , Estilbenos/farmacocinética
10.
Molecules ; 15(7): 4722-36, 2010 Jul 06.
Artigo em Inglês | MEDLINE | ID: mdl-20657388

RESUMO

The regioselective synthesis of several quercetin (3,3',4',5,7-pentahydroxy flavone) tetraesters bearing a single free OH on 5-C was achieved in good yield by proper choice of reaction conditions using common esterification procedures. Tetracetylated quercetin with the free OH on 7-C was selectively obtained instead via imidazole-promoted deacylation of the corresponding pentaester. Unambiguous structural characterization of the two isomeric tetraacetyl quercetin derivatives was obtained by combined HSQC and HMBC 2D-NMR analysis. These molecules can be used as starting materials for the regioselective synthesis of other derivatives. High yield syntheses of the natural polyphenol rhamnetin (7-O-methylquercetin) and of the new mitochondriotropic compound 7-(4-triphenylphosphoniumbutyl) quercetin iodide are reported as examples.


Assuntos
Mitocôndrias/metabolismo , Quercetina/análogos & derivados , Animais , Ésteres/química , Humanos , Estrutura Molecular , Quercetina/síntese química , Quercetina/química
11.
Cell Physiol Biochem ; 23(4-6): 425-30, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19471110

RESUMO

Caco-2 cells are widely used for transepithelial transport and metabolism studies. We analysed the metabolites produced from quercetin (Q) during transport of this flavonoid across Caco-2 monolayers and by plastic-adhering cells. We found that the pattern of Phase II metabolic activity varies markedly depending on the particular cell clone, age of the cell culture, and stressful treatment such as freezing/thawing. Prolonged culturing and stress cause a decrease of "detoxifying" conjugating activity. This can be re-established by growing the cells with a low concentration of the transport/metabolism substrate for a few days. We suggest this metabolism-activating procedure be used to make studies with these cells more readily comparable.


Assuntos
Quercetina/metabolismo , Células CACO-2 , Linhagem Celular , Cromatografia Líquida de Alta Pressão , Congelamento , Humanos , Desintoxicação Metabólica Fase II , Quercetina/análise , Quercetina/isolamento & purificação , Espectrometria de Massas por Ionização por Electrospray , Sulfotransferases/metabolismo
12.
Cell Physiol Biochem ; 24(5-6): 557-66, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19910696

RESUMO

Model prodrugs of resveratrol carrying protecting substituents at the hydroxyls have been synthesised and tested. Resveratrol triacetate and resveratrol-tri-mPEG(1900) were formed by linking methyl groups or poly(ethylene glycol) chains, respectively, via carboxyester bonds. Resveratrol trimesylate, a molecule less susceptible to hydrolytic attack, was synthesised as well. This latter compound proved to be stable in vitro, while the carboxyester derivatives were slowly hydrolysed in solutions mimicking the gastric or intestinal environment, and rapidly converted to resveratrol in blood. In ex vivo permeation experiments with explanted intestinal segments, resveratrol and its triacetate derivative appeared in the basolateral compartment essentially as a mixture of Phase II metabolites. When the PEGylated derivative was provided on the apical side, unconjugated resveratrol accounted for about 50% of the compounds in the basolateral-side chamber. The same result was obtained by providing an equivalent physical mixture of resveratrol and PEG polymer, indicating that this behaviour is likely due to an adjuvating effect of PEG rather than to the covalent polymer conjugation. These observations suggest that the ester derivatives are rapidly hydrolysed at the intestinal surface or inside enterocytes, and are then processed as resveratrol. On the other hand, the mesylate was transported from the apical to the basolateral side without modification. It may thus be possible to enhance absorption and hinder metabolism of natural polyphenols by constructing pro-drugs incorporating bonds with appropriate resistance to enzymatic hydrolysis.


Assuntos
Anti-Inflamatórios não Esteroides/farmacocinética , Mucosa Intestinal/metabolismo , Pró-Fármacos/farmacocinética , Estilbenos/farmacocinética , Animais , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/química , Polietilenoglicóis/química , Ratos , Resveratrol , Estilbenos/síntese química , Estilbenos/química
13.
J Nutr Biochem ; 20(2): 87-95, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18495463

RESUMO

Curcumin (Cur), a component of turmeric (Curcuma longa), has been reported to exhibit antimetastatic activities, but the mechanisms remain unclear. Other curcuminoids present in turmeric, demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC) have not been investigated whether they exhibit antimetastatic activity to the same extent as curcumin. The regulation of matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA) play important role in cancer cell invasion by cleavage of extracellular matrix (ECM). In this line, we comparatively examined the influence of Cur, DMC and BDMC on the expressions of uPA, MMP-2, MMP-9, membrane Type 1 MMP (MT1-MMP), tissue inhibitor of metalloproteinases (TIMP-2), and in vitro invasiveness of human fibrosarcoma cells. The results indicate that the differential potency for inhibition of cancer cell invasion was BDMC> or =DMC>Cur, whereas the cell migration was not affected. Zymography analysis exhibited that curcumin, DMC and BDMC significantly decreased uPA, active-MMP-2 and MMP-9 but not pro-MMP-2 secretion from the cells in a dose-dependent manner, in which BDMC and DMC show higher potency than curcumin. The suppression of active MMP-2 level correlated with inhibition of MT1-MMP and TIMP-2 protein levels involved in pro-MMP-2 activation. Importantly, BDMC and DMC at 10 microM reduced MT1-MMP and TIMP-2 protein expression, but curcumin slightly reduced only MT1-MMP but not TIMP-2. In addition, three forms of curcuminoids significantly inhibited collagenase, MMP-2, and MMP-9 but not uPA activity. In summary, these data demonstrated that DMC and BDMC show higher antimetastasis potency than curcumin by the differentially down-regulation of ECM degradation enzymes.


Assuntos
Curcumina/análogos & derivados , Curcumina/uso terapêutico , Metaloproteinases da Matriz/metabolismo , Invasividade Neoplásica/prevenção & controle , Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Células 3T3 , Animais , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Diarileptanoides , Fibrossarcoma , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Humanos , Metaloproteinases da Matriz/efeitos dos fármacos , Metaloproteinases da Matriz/genética , Camundongos , Ativador de Plasminogênio Tipo Uroquinase/efeitos dos fármacos , Ativador de Plasminogênio Tipo Uroquinase/genética
14.
Bioorg Med Chem Lett ; 19(23): 6721-4, 2009 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-19846300

RESUMO

We report the development of a chemical modification method of general applicability to polyphenols, which increases solubility to influence absorption. Glucosyl groups were added to the resveratrol kernel via a succinate linker, yielding 3,4',5-tri-(alpha-D-glucose-3-O-succinyl) resveratrol. The construct was only slowly hydrolyzed in acid and at pH 6.8, but it was destroyed by blood esterases in less than 1h. In rats its administration resulted in a blood concentration versus time curve shifted to longer times in comparison to resveratrol, a useful modulation of pharmacokinetics. The area-under-curve parameter and the metabolite mix were similar to those of resveratrol. The method may be advantageously employed to solubilize other polyphenols and to make them more palatable.


Assuntos
Flavonoides/síntese química , Flavonoides/farmacocinética , Glucosídeos/síntese química , Glucosídeos/farmacocinética , Fenóis/síntese química , Fenóis/farmacocinética , Estilbenos/síntese química , Estilbenos/farmacocinética , Animais , Disponibilidade Biológica , Flavonoides/química , Glucosídeos/química , Estrutura Molecular , Fenóis/química , Polifenóis , Ratos , Solubilidade , Estilbenos/química , Fatores de Tempo
15.
J Leukoc Biol ; 83(1): 212-9, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17947392

RESUMO

Hyperforin (Hyp) is an active compound contained in the extract of Hypericum perforatum, well known for its antidepressant activity. However, Hyp has been found to possess several other biological properties, including inhibitory effects on tumor invasion, angiogenesis, and inflammation. In this paper, we show that treatment with Hyp inhibited IFN-gamma production, with down-regulation of T-box (T-bet; marker of Th1 gene expression) and up-regulation of GATA-3 (marker gene of Th2) on IL-2/PHA-activated T cells. In parallel, we showed a strong down-regulation of the chemokine receptor CXCR3 expression on activated T cells. The latter effect and the down-modulation of matrix metalloproteinase 9 expression may eventually lead to the inhibition of migratory capability and matrix traversal toward the chemoattractant CXCL10 by activated lymphocytes that we observed in vitro. The effect of Hyp was thus evaluated on an animal model of experimental allergic encephalomyelitis (EAE), a classic, Th1-mediated autoimmune disease of the CNS, and we observed that Hyp attenuates the severity of the disease symptoms significantly. Together, these properties qualify Hyp as a putative, therapeutic molecule for the treatment of autoimmune inflammatory disease sustained by Th1 cells, including EAE.


Assuntos
Encefalomielite Autoimune Experimental/tratamento farmacológico , Floroglucinol/análogos & derivados , Linfócitos T/efeitos dos fármacos , Terpenos/farmacologia , Células Th1/efeitos dos fármacos , Animais , Compostos Bicíclicos com Pontes/farmacologia , Compostos Bicíclicos com Pontes/uso terapêutico , Sobrevivência Celular/efeitos dos fármacos , Modelos Animais de Doenças , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/imunologia , Encefalomielite Autoimune Experimental/imunologia , Feminino , Fator de Transcrição GATA3/efeitos dos fármacos , Fator de Transcrição GATA3/metabolismo , Humanos , Interferon gama/antagonistas & inibidores , Interferon gama/biossíntese , Interferon gama/imunologia , Interleucina-2/farmacologia , Floroglucinol/farmacologia , Floroglucinol/uso terapêutico , Fito-Hemaglutininas/farmacologia , Ratos , Ratos Endogâmicos Lew , Receptores CXCR3/biossíntese , Receptores CXCR3/efeitos dos fármacos , Proteínas com Domínio T/efeitos dos fármacos , Proteínas com Domínio T/metabolismo , Linfócitos T/imunologia , Terpenos/uso terapêutico , Células Th1/imunologia , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/imunologia
16.
Chembiochem ; 9(16): 2633-42, 2008 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-18837061

RESUMO

Mitochondria-targeted compounds are needed to act on a variety of processes that take place in these subcellular organelles and that have great pathophysiological relevance. In particular, redox-active molecules that are capable of homing in on mitochondria provide a tool to intervene on a major cellular source of reactive oxygen species and on the processes they induce, notably the mitochondrial permeability transition and cell death. We have linked the 3-OH of quercetin (3,3',4',5,7-pentahydroxy flavone), a model polyphenol, and the triphenylphosphonium moiety, a membrane-permeant cationic group, to produce proof-of-principle mitochondriotropic quercetin derivatives. The remaining hydroxyls were sometimes acetylated to hinder metabolism and improve solubility. The new compounds accumulate in mitochondria in a transmembrane potential-driven process and are only slowly metabolised by cultured human colon cells. They inhibit mitochondrial ATPase activity much as quercetin does, and are toxic for fast-growing cells.


Assuntos
Flavonoides/química , Flavonoides/metabolismo , Mitocôndrias/metabolismo , Fenóis/química , Fenóis/metabolismo , Quercetina/química , Quercetina/metabolismo , Animais , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Flavonoides/síntese química , Flavonoides/farmacologia , Humanos , Camundongos , Fenóis/síntese química , Fenóis/farmacologia , Polifenóis , Quercetina/síntese química , Quercetina/farmacologia , Ratos , Solubilidade , Água/química
17.
J Nutr ; 138(9): 1596-601, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18716156

RESUMO

We previously documented a clear-cut antihypertensive effect of green teat extract (GTE), which was associated with correction of endothelial dysfunction and prevention of left ventricular hypertrophy in an angiotensin II (Ang II)-dependent model of hypertension, but the molecular mechanisms remain to be defined. As several effects of Ang II involve production of reactive oxygen species (ROS) and activation of 2nd messengers, such as mitogen-activated protein kinase (MAPK) and Akt, we investigated the effect of GTE on these signal transduction pathways in Ang II-treated rats. Rats were treated for 2 wk with Ang II infusion (700 mug.kg(-1).d(-1); n = 6, via osmotic minipumps), Ang II plus GTE (6 g/L) dissolved in the drinking water; n = 6), or vehicle (n = 6) to serve as controls. Blood pressure was monitored by telemetry throughout the study. The activation and expression of NAD(P)H oxidase subunits, protein kinase C isoforms, Src, epidermal growth factor receptor (EGFR), Akt, and MAPK were determined in the heart in vitro through immunoprecipitation and western blot analysis with specific antibodies. NAD(P)H oxidase enzymatic activity was measured by cytochrome c reduction assay. GTE blunted Ang II-induced blood pressure increase and cardiac hypertrophy. In Ang II-treated rats, GTE decreased the expression of the NAD(P)H oxidase subunit gp91(phox) and the translocation of Rac-1, as well as NAD(P)H oxidase enzymatic activity. Furthermore, it specifically reduced Ang II-induced Src, EGFR, and Akt phosphorylation. These results show that GTE blunts Ang II-induced cardiac hypertrophy specifically by regulating ROS production and the Src/EGFR/Akt signaling pathway activated by Ang II.


Assuntos
Cardiomegalia/tratamento farmacológico , Receptores ErbB/metabolismo , Proteína Oncogênica v-akt/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Chá , Quinases da Família src/metabolismo , Angiotensina II/toxicidade , Animais , Cardiomegalia/induzido quimicamente , Cardiomegalia/metabolismo , Ativação Enzimática , Isoenzimas , Masculino , Proteínas Quinases Ativadas por Mitógeno/genética , Proteínas Quinases Ativadas por Mitógeno/metabolismo , NADPH Oxidases/metabolismo , Proteína Oncogênica v-akt/genética , Proteína Quinase C/química , Proteína Quinase C/genética , Proteína Quinase C/metabolismo , Subunidades Proteicas , Ratos , Ratos Sprague-Dawley , Transdução de Sinais
18.
Bioorg Med Chem Lett ; 18(20): 5594-7, 2008 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-18823777

RESUMO

To target natural polyphenols to the subcellular site where their redox properties might be exploited at best, that is, mitochondria, we have synthesised new proof-of-principle derivatives by linking resveratrol (3,4',5-trihydroxy-trans-stilbene) to the membrane-permeable lipophilic triphenylphosphonium cation. The new compounds, (4-triphenylphosphoniumbutyl)-4'-O-resveratrol iodide and its bis-acetylated derivative, the latter intended to provide transient protection against metabolic conjugation, accumulate into energized mitochondria as expected and are cytotoxic for fast-growing but not for slower-growing cells. They provide a powerful potential tool to intervene on mitochondrial and cellular redox processes of pathophysiological relevance.


Assuntos
Antioxidantes/síntese química , Química Farmacêutica/métodos , Mitocôndrias/metabolismo , Estilbenos/síntese química , Animais , Antioxidantes/farmacologia , Cátions , Desenho de Fármacos , Flavonoides/química , Mitocôndrias Hepáticas/metabolismo , Oxidantes/química , Oxirredução , Fenóis/química , Polifenóis , Ratos , Espécies Reativas de Oxigênio , Resveratrol , Solubilidade , Estilbenos/farmacologia , Água/química
19.
Acta Pharmacol Sin ; 29(7): 853-60, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18565284

RESUMO

AIM: Tetrahydrocurcumin (THC) is an active metabolite of curcumin. It has been reported to have similar pharmacological activity to curcumin. The proteases that participate in extracellular matrix (ECM) degradation are involved in cancer cell metastasis. The present study investigates the effect of an ultimate metabolite of curcumin, THC, on the invasion and motility of highly-metastatic HT1080 human fibrosarcoma cells. METHODS: The effect of THC on HT1080 cell invasion and migration was determined using Boyden chamber assay. Cell-adhesion assay was used for examining the binding of cells to ECM molecules. Zymography assay was used to analyze the effect of THC on matrix metalloproteinase (MMP)-2, MMP-9, and urokinase plasminogen activator (uPA) secretion from HT1080 cells. Tissue inhibitor of metalloproteinase (TIMP)-2 and membrane-type 1 matrix metalloproteinase (MT1-MMP) proteins levels were analyzed by Western blotting. RESULTS: Treatment with THC reduced HT1080 cell invasion and migration in a dose-dependent manner. THC also decreased the cell adhesion to Matrigel and laminin-coated plates. Analysis by zymography demonstrated that treatment with THC reduced the levels of MMP-2, MMP-9, and uPA. THC also inhibited the levels of MT1-MMP and TIMP-2 proteins detected by Western blot analysis. CONCLUSION: Our findings revealed that THC reduced HT1080 cell invasion and migration. The inhibition of cancer cell invasion is associated with the downregulation of ECM degradation enzymes and the inhibition of cell adhesion to ECM proteins.


Assuntos
Anticarcinógenos/farmacologia , Movimento Celular/efeitos dos fármacos , Curcumina/análogos & derivados , Metaloproteinases da Matriz/biossíntese , Ativador de Plasminogênio Tipo Uroquinase/biossíntese , Animais , Linhagem Celular Tumoral , Curcumina/farmacologia , Regulação para Baixo/efeitos dos fármacos , Humanos , Camundongos , Células NIH 3T3 , Invasividade Neoplásica/patologia
20.
Chest ; 132(6): 1733-40, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17646237

RESUMO

BACKGROUND: There is increasing evidence that matrix metalloproteinases (MMPs) may contribute to the pathogenesis of COPD, but their role in humans is not completely understood. We performed this study to quantify the expression of MMP-2 in a population of COPD patients at different stages of severity. METHODS: We collected surgical specimens from 46 subjects, as follows: 10 smokers with severe COPD (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage III-IV); 13 smokers with mild/moderate COPD (GOLD stage I-II); 12 control smokers; and 11 nonsmoking control subjects. We quantified MMP-2 expression in alveolar macrophages, alveolar walls, peripheral airways, and pulmonary arterioles by immunohistochemistry. RESULTS: In all compartments, MMP-2 expression was increased both in smokers with severe COPD and in smokers with mild/moderate COPD compared to control smokers and nonsmokers (p < 0.05 for all comparisons). Only in alveolar macrophages was MMP-2 expression increased in smokers with severe COPD compared to smokers with mild/moderate COPD (p = c0.002). Moreover, MMP-2 expression was inversely related to values of FEV1/FVC ratio (p < 0.0001; r = -0.71) and Pao2 (in millimeters of Hg) [p = 0.005; r = -0.49], and was positively related to emphysema score (p = 0.01; r = 0.65) and residual volume percent predicted (p = 0.04; r = 0.49). A stepwise increase in the total number of alveolar macrophages was observed in the four groups of subjects examined, with the highest value in those with severe COPD. CONCLUSION: This study shows that MMP-2 expression in the lung periphery progressively increases as lung function worsens and the degree of emphysema increases. These results suggest that MMP-2 may be a key mediator of the mechanisms leading to lung tissue remodeling and inflammation in patients with severe COPD.


Assuntos
Metaloproteinase 2 da Matriz/metabolismo , Doença Pulmonar Obstrutiva Crônica/enzimologia , Idoso , Progressão da Doença , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Testes de Função Respiratória , Índice de Gravidade de Doença , Fumar/efeitos adversos , Estatísticas não Paramétricas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA